Osteopontin Is Expressed in Human Aortic Valvular Lesions
- 15 October 1995
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 92 (8), 2163-2168
- https://doi.org/10.1161/01.cir.92.8.2163
Abstract
Background Nonrheumatic stenosis of trileaflet aortic valves, in which calcification is a prominent feature, has been termed a “degenerative” condition, but it has been demonstrated recently that chronic inflammation is a characteristic feature of the developing lesion of aortic stenosis. This observation raised the possibility that calcification in the aortic valve might be actively regulated. Thus, the present study investigated whether osteopontin, a protein implicated in the regulation of both normal and dystrophic calcification, could be detected in lesions of valvular aortic stenosis. Methods and Results Morphological and immunohistochemical studies were performed on 14 human aortic valves, representing a range of pathology from normal to clinically stenotic. The extent of calcification and macrophage accumulation and their relation to the presence of osteopontin protein were characterized. Highly statistically significant associations were found between the degree of osteopontin expression and the degrees of both calcification and macrophage accumulation in early through late lesions of aortic stenosis. Further, in situ hybridization localized osteopontin mRNA to a subset of lesion macrophages. Conclusions These results suggest that, rather than representing a degenerative and unmodifiable process, calcification in aortic stenosis may be, in part, an actively regulated process with the potential for control either through modification of inflammation or synthesis of proteins such as osteopontin, which may modulate calcification in this tissue.Keywords
This publication has 33 references indexed in Scilit:
- Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis.JCI Insight, 1994
- High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.JCI Insight, 1994
- TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.JCI Insight, 1994
- Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.JCI Insight, 1993
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.JCI Insight, 1992
- Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontinBiochemical and Biophysical Research Communications, 1992
- Structure and Expression of Osteonectin Mrna in Human TissueConnective Tissue Research, 1990
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986
- The senile cardiac calcification syndromeThe American Journal of Cardiology, 1986